Rodrigo Ruiz Soto
Directeur Technique/Scientifique/R&D chez DECIPHERA PHARMACEUTICALS, INC.
Postes actifs de Rodrigo Ruiz Soto
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2017 | - |
| IMMUNOGEN, INC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Rodrigo Ruiz Soto
Anciens postes connus de Rodrigo Ruiz Soto
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Rodrigo Ruiz Soto
| Universidad Nacional Autónoma de México | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Mexique | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Retail Trade | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Rodrigo Ruiz Soto
- Expérience